Loading...
Loading...
BWAY| Name | Value |
|---|---|
| Revenues | 10.5M |
| Cost of Revenue | 2.8M |
| Gross Profit | 7.7M |
| Operating Expense | 7.4M |
| Operating I/L | 0.3M |
| Other Income/Expense | 0.5M |
| Interest Income | 0.8M |
| Pretax | 0.7M |
| Income Tax Expense | 0.1M |
| Net Income/Loss | 0.7M |
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders globally. The company's Deep Transcranial Magnetic Stimulation platform technology is used for treating a wide range of conditions including major depressive disorders, obsessive-compulsive disorders, bipolar disorders, and Parkinson's diseases. Brainsway primarily serves the psychiatry field, providing its innovative treatments to doctors, hospitals, and medical centers. By offering effective solutions for various mental health disorders, the company generates revenue through the sale of its neurostimulation treatments and related services.
